Geoffrey Kempler
Patrimonio netto: 130 150 $ in data 31/08/2026
Patrimonio netto: 130 150 $ in data 31/08/2026
Geoffrey Paul Kempler was the founder of Alterity Therapeutics Ltd., founded in 1997, where the title held was Non-Executive Chairman from 2021 to 2025.
Mr. Kempler is currently Chairman & Managing Director at Hexima Ltd. since 2023.
Former positions include Chairman at Opthea Ltd. from 2015 to 2020 and Chairman at AusBiotech Ltd. from 2021 to 2023.
Education includes undergraduate studies at Monash University.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 21/11/2025 | 359.620 ( 0,16% ) | 130 150 $ | 31/08/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| HEXIMA LIMITED | Amministratore Delegato | 05/09/2023 |
| Società | Posizione | Fine |
|---|---|---|
| ALTERITY THERAPEUTICS LIMITED | Amministratore Delegato | 07/01/2021 |
AusBiotech Ltd.
AusBiotech Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology membership company | Presidente | 01/11/2023 |
| CERYVYN THERAPEUTICS LIMITED | Presidente | 12/10/2020 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 5 |
|---|---|
Hexima Ltd.
Hexima Ltd. BiotechnologyHealth Technology Engages in research and development of plant-derived proteins for treatment of fungal nail infections and provides commercial property services | Health Technology |
Opthea Ltd.
Opthea Ltd. BiotechnologyHealth Technology Operates as a biotechnology company that develops novel therapies for treatment retinal diseases | Health Technology |
Alterity Therapeutics Ltd.
Alterity Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops therapeutic drugs | Health Technology |
Monash University
Monash University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AusBiotech Ltd.
AusBiotech Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology membership company | Commercial Services |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale